Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121631002 | 12163100 | 2 | F | 20160122 | 20160811 | 20160309 | 20160818 | PER | US-CELGENEUS-USA-2016030937 | CELGENE | 69.48 | YR | F | Y | 109.87000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121631002 | 12163100 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | Y | UNKNOWN | 21880 | 25 | MG | CAPSULES | |||||
| 121631002 | 12163100 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | N | Y | UNKNOWN | 21880 | 15 | MG | CAPSULES | |||||
| 121631002 | 12163100 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 121631002 | 12163100 | 4 | C | Potassium | POTASSIUM | 1 | Intravenous drip | 0 | INJECTION FOR INFUSION | ||||||||||
| 121631002 | 12163100 | 5 | C | Bortezomib | BORTEZOMIB | 1 | Subcutaneous | 0 | 3 | MG | INJECTION | ||||||||
| 121631002 | 12163100 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
| 121631002 | 12163100 | 7 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | UNKNOWN | QD | |||||||
| 121631002 | 12163100 | 8 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0 | 120 | MG | INJECTION | QD | |||||||
| 121631002 | 12163100 | 9 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 40 | MG | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121631002 | 12163100 | 1 | Plasma cell myeloma |
| 121631002 | 12163100 | 3 | Product used for unknown indication |
| 121631002 | 12163100 | 4 | Blood potassium |
| 121631002 | 12163100 | 5 | Plasma cell myeloma |
| 121631002 | 12163100 | 6 | Hypertension |
| 121631002 | 12163100 | 7 | Hypertension |
| 121631002 | 12163100 | 8 | Pulmonary embolism |
| 121631002 | 12163100 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121631002 | 12163100 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121631002 | 12163100 | Diarrhoea | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121631002 | 12163100 | 1 | 20151120 | 0 | ||
| 121631002 | 12163100 | 2 | 201602 | 20160316 | 0 | |
| 121631002 | 12163100 | 4 | 20160301 | 0 | ||
| 121631002 | 12163100 | 5 | 20151201 | 20160325 | 0 | |
| 121631002 | 12163100 | 6 | 20151102 | 0 | ||
| 121631002 | 12163100 | 7 | 20151102 | 0 | ||
| 121631002 | 12163100 | 8 | 20160111 | 0 | ||
| 121631002 | 12163100 | 9 | 20151104 | 20160511 | 0 |